Botanical species · safety record
Plantago major
The EFSA Compendium of Botanicals holds 2 constituent measurements, 1 adverse-effect record and 1 genotoxicity assay for Plantago major. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Plantago major L.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 161 licensed products naming Plantago major as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- Erucic acid1
- Oxalates1
Plant parts
- Leaves3
Preparations
- Solvent extraction3
Effect types
- Other toxicities1
Target tissues
- Neurologic: central nervous system1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Erucic acid | Leaves | Solvent extraction | 3.45 Percent | Gaschromatography (GC) | Resolve DOI |
| Oxalates | Leaves | Solvent extraction | 0.67 Milligram/100 gram | Colorimetry, Spectroscopy (Spectrometry) and Photometry | Resolve DOI |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Other toxicities | Neurologic: central nervous system | Leaves | Solvent extraction | Rat (as animal) | Subchronic | No resolvable identifier |
Genotoxicity testing
Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.
| Outcome | Endpoint | Test | Tested organism | Metabolic activation | Source |
|---|---|---|---|---|---|
| Positive | genome mutation | somatic mutation assay in Drosophila | Drosophila melanogaster (as animal) | — | Resolve DOI |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Guil, JL., Rodriguez-Garcia, I., Torija, E. Nutritional and toxic factors in selected wild edible plants. PLANT FOODS FOR HUMAN NUTRITION, 1997, vol. 51, no. 2, p. 99-107. DOI
- Pimenta, VMSD., Nepomuceno, JC. Genotoxicity testing of Plantago major extracts in somatic cells of Drosophila melanogaster . Environmental and molecular mutagenesis, 2005, vol. 45, no. 1, p. 56-61. DOI
- Gonzalez, MG., Coto-Morales, T., Rodriguez, GAS., Pazos, L. Sub-chronic toxicity and test of eye irritability of leaf aqueous extract from Plantago major (Plantaginaceae) . Revista de biologia tropical, 2003, vol. 51, no. 3-4, p. 635-638.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.